Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan(National Cancer Institute), Jane Churpek(University of Wisconsin–Madison), Betsy Morrow(National Institutes of Health), Mark Raffeld(National Cancer Institute), Christine Alewine(Dartmouth Psychiatric Research Center), Emerson Padiernos(Center for Cancer Research), Arpita Desai(University of California, San Francisco), Liqiang Xi(Center for Cancer Research), David S. Schrump(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Süleyman Gülsüner(University of Washington Medical Center), Jun S. Wei(Center for Cancer Research), Mary‐Claire King(University of Washington), Meghana Gadiraju(University of Chicago), Anish Thomas(National Cancer Institute), Mary Hesdorffer(Mesothelioma Applied Research Foundation), Ming K. Lee(University of Washington Medical Center), Tom Walsh(University of Washington), Snehal Patel(Center for Cancer Research), Hedy L. Kindler(University of Chicago), Jingli Zhang(Queensland University of Technology), Idrees Mian(National Institutes of Health), Vasiliki Panou(University of Southern Denmark), Shaojian Gao(Center for Cancer Research), Javed Khan(Kent State University)
Cited by 157
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
|Journal of Clinical Oncology|2010|840
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817